Amitriptyline is a potent blocker of human Kv1.1 and Kv7.2/7.3 channels

Anesthesia and Analgesia

Volumn 104, Issue 5, 2007, Pages 1256-1264

  Punke, Mark A ^a   Friederich, Patrick ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; POTASSIUM CHANNEL; POTASSIUM CHANNEL KV1.1; POTASSIUM CHANNEL KV7.2; POTASSIUM CHANNEL KV7.3; RETIGABINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL MEMBRANE DEPOLARIZATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG INHIBITION; DRUG MECHANISM; EMBRYO; FEMALE; HAMSTER; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IC 50; MEMBRANE STEADY POTENTIAL; NONHUMAN; NUCLEOTIDE SEQUENCE; PATCH CLAMP; PRIORITY JOURNAL;

AMITRIPTYLINE; ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KCNQ2 POTASSIUM CHANNEL; KCNQ3 POTASSIUM CHANNEL; KV1.1 POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKERS;

EID: 34247549124     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000260310.63117.a2     Document Type: Article

References (37)

1. Passmore GM, Selyanko AA, Mistry M, et al. KCNQ/M currents in sensory neurons: significance for pain therapy. J Neurosci 2003;23:7227-36.
2. Clark JD, Tempel BL. Hyperalgesia in mice lacking the Kv1.1 potassium channel gene. Neurosci Lett 1998;251:121-4.
3. Rasband MN, Park EW, Vanderah TW, et al. Distinct potassium channels on pain-sensing neurons. Proc Natl Acad Sci USA 2001;98:13373-8.
4. Beekwilder JP, O'Leary ME, van den Broek LP, et al. Kv1.1 channels of dorsal root ganglion neurons are inhibited by n-butyl-p- aminobenzoate, a promising anesthetic for the treatment of chronic pain. J Pharmacol Exp Ther 2003;304:531-8.
5. Cooper EC, Aldape KD, Abosch A, et al. Colocalization and coassembly of two human brain M-type potassium channel subunits that are mutated in epilepsy. Proc Natl Acad Sci USA 2000;97:4914-19.
6. Suzuki R, Dickenson AH. Neuropathic pain: nerves bursting with excitement. Neuroreport 2000;11:R17-R21.
7. Smart SL, Lopantsev V, Zhang CL, et al. Deletion of the K(V)1.1 potassium channel causes epilepsy in mice. Neuron 1998;20:809-19.
8. Biervert C, Schroeder BC, Kubisch C, et al. A potassium channel mutation in neonatal human epilepsy. Science 1998;279:403-6.
9. Korsgaard MP, Hartz BP, Brown WD, et al. Anxiolytic effects of Maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels. Pharmacol Exp Ther 2005;314:282-92.
10. Richeimer SH, Bajwa ZH, Kahraman SS, et al. Utilization patterns of tricyclic antidepressants in a multidisciplinary pain clinic: a survey. Clin J Pain 1997;13:324-9.
11. Max MB, Culnane M, Schafer SC, et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987;37:589-96.
12. Watson CP, Evans RJ, Reed K, et al. Amitriptyline versus placebo in postherpetic neuralgia. Neurology 1982;32:671-3.
13. Preskorn SH, Fast GA. Tricyclic antidepressant-induced seizures and plasma drug concentration. J Clin Psychiatry 1992;53:160-2.
14. Henry JA. Epidemiology and relative toxicity of antidepressant drugs in overdose. Drug Saf 1997;16:374-90.
15. Galeotti N, Ghelardini C, Bartolini A. Involvement of the serotonergic system in the analgesic effect of tricyclic antidepressants. Behav Pharmacol 1985;6:20-1.
16. Sacerdote P, Brini A, Mantegazza P, Panerai AE. A role for serotonin and β-endorphin in the analgesia induced by some tricyclic antidepressant drugs. Pharmacol Biochem Behav 1987;26:153-8.
17. Song JH, Ham SS, Shin YK, Lee CS. Amitriptyline modulation of Na(+-) channels in rat dorsal root ganglion neurons. Eur J Pharmacol 2000;401:297-305.
18. Sanchez C, Hyttel J. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell Mol Neurobiol 1999;19:467-89.
19. Lee K, McKenna F, Rowe IC, Ashford ML. The effects of neuroleptic and tricyclic compounds on BKCa channel activity in rat isolated cortical neurones. Br J Pharmacol 1997;121:1810-16.
20. Gray AM, Pache DM, Sewell RD. Do α-adrenoceptors play an integral role in the antinociceptive mechanism of action of antidepressant compounds? Eur J Pharmacol 1999;378:161-8.
21. + channels by amitriptyline via the local anesthetic receptor and its implication for neuropathic pain. Pain 2004;110:166-74.
22. + channel. Eur J Pharmacol 1997;330:15-25.
23. Galeotti N, Ghelardini C, Bartolini A. Involvement of potassium channels in amitriptyline and clomipramine analgesia. Neuropharmacology 2001;40:75-84.
24. Rundfeldt C, Netzer R. The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells transfected with human KCNQ2/3 subunits. Neurosci Lett 2000;282:73-6.
25. Tatulian L, Delmas P, Abogadie FC, Brown DA. Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine. J Neurosci 2001;21:5535-45.
26. Rostock A, Tober C, Rundfeldt C, et al. D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures. Epilepsy Res 1996;23:211-23.
27. Bialer M, Johannessen SI, Kupferberg HJ, et al. Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI). Epilepsy Res 2002;51:31-71.
28. Dost R, Rostock A, Rundfeldt C. The anti-hyperalgesic activity of retigabine is mediated by KCNQ potassium channel activation. Naunyn Schmiedebergs Arch Pharmacol 2004;369:382-90.
29. Friederich P, Benzenberg D, Trellakis S, Urban BW. Interaction of volatile anesthetics with human Kv channels in relation to clinical concentrations. Anesthesiology 2001;95:954-8.
30. Punke MA, Friederich P. Retigabine stimulates human KCNQ2/Q3 channels in the presence of bupivacaine. Anesthesiology 2004;101:430-8.
31. Hamill OP, Marty A, Neher E, et al. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 1981;391:85-100.
32. + current in a vertebrate neurone. Nature 1980;14:673-6.
33. Wang HS, Pan Z, Shi W, et al. KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science 1998;282:1890-3.
34. Armstrong CM. Inactivation of the potassium conductance and related phenomena caused by quaternary ammonium ion injection in squid axons. J Gen Physiol 1969;54:553-75.
35. Armstrong CM. Interaction of tetraethylammonium ion derivatives with the potassium channels of giant axons. J Gen Physiol 1971;58:413-37.
36. Wickenden AD, Yu W, Zou A, et al. Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels. Mol Pharmacol 2000;58:591-600.
37. + channels causes epilepsy. Nature 1998;396:687-90.